The two companies expect supply to commence later this year. This announcement builds upon an agreement reached by the two companies in September 2021.
Ac-225 is used in targeted alpha therapies (TATs). This emerging field combines Ac-225 with specific tumor-seeking targeting moieties that deliver alpha radiation directly to tumors.
Copyright © 2022 AuntMinnie.com